查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区诊断质谱和层析法分析市场按产品类型、应用类型和国家分類的分析与预测（2024-2033 年）
市场调查报告书
商品编码
1657956

亚太地区诊断质谱和层析法分析市场按产品类型、应用类型和国家分類的分析与预测（2024-2033 年）

Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market: Focus on Product Type, Application Type, and Country - Analysis and Forecast, 2024-2033
出版日期: | 出版商: BIS Research | 英文 56 Pages | 商品交期: 1-5个工作天内

价格

到 2024 年，亚太地区质谱和层析法诊断市场规模预计将达到 1.542 亿美元。

预计到 2033 年，该市场规模将达到 4.287 亿美元，2024-2033 年预测期内的复合年增长率为 12.04%。亚太地区质谱（MS）和层析法市场是分析和生命科学仪器领域的主要部分，为生物和化学对象的分离、鑑定和定量提供尖端解决方案。製药、环境监测、诊断和食品安全等许多行业都受益于这些技术。

质谱法和层析法通常不会单独使用，而是整合到诊断工作流程中。例如，液相层析法质谱法（LC-MS）是一种分析复杂样品的高效技术，因为它结合了质谱的检测能力和液相层析法的分离效率。这种整合在临床环境中尤其有益，因为对患者样本进行高通量分析可以实现准确的诊断和治疗计划。

主要市场统计数据
预测期 2024-2033
2024 年评估 1.542亿美元
2033 年预测 4.287亿美元
复合年增长率 12.04％

亚太地区层析法和质谱技术的主要诊断应用包括维生素分析、荷尔蒙分析和生物标记发现。随着精准医疗、代谢体学和蛋白​​质组学的日益普及，这些技术预计将因医疗保健投资的增加、技术进步和先进诊断工具的普及而经历广泛的增长。

由于临床诊断的复杂性日益增加以及精准医疗的需求，亚太地区诊断市场的质谱和层析法正在显着增长。质谱 (MS) 和层析法是化学和生物物质的分离、鑑定和定量所必需的，因此是诊断和监测许多疾病（包括癌症、代谢紊乱和感染疾病）的重要工具。

液相层析法质谱 (LC-MS) 等技术广泛应用于诊断工作流程，可实现患者样本的高通量和精确分析。这些混合系统结合了质谱和分离功能，为临床环境中复杂样本的分析提供了完整的解决方案。它在蛋白质组学、代谢体学和生物标记发现、增强诊断能力和个人化医疗方面发挥关键作用。

有针对性的药物测试、代谢分析、维生素和荷尔蒙分析是重要的诊断应用。人们对早期疾病检测和个人化治疗方案的关注度日益提高，推动了对这些尖端诊断工具的需求。

政府的早期检测计划、扩大医疗保健基础设施以及自动化和人工智慧主导的分析等技术发展都在促进市场发展。随着亚太地区医疗保健系统采用更复杂的诊断工具，改善全部区域的患者治疗效果和医疗保健效果，质谱和层析法市场预计将继续成长。

本报告研究了亚太地区诊断质谱和层析法市场，并概述了市场概况、产品类型、应用类型和国家的趋势，以及参与市场的公司概况。

目录

执行摘要

第 1 章 诊断市场中的质谱和层析法：产业展望

  • 市场概况
  • 主要趋势
  • 主要趋势的机会评估
  • 产品基准
  • 监管状态
    • 亚太法规结构

2. 诊断市场中的质谱和层析法（按地区）

  • 区域概况
  • 亚太地区

3. 诊断市场中的质谱和层析法：竞争基准化分析和公司概况

  • 竞争格局
    • 伙伴关係、合作和业务扩展
    • 新服务
    • 合併和收购
    • 监管部门核准
  • 关键策略和发展
  • 企业竞赛矩阵
  • 企业市场占有率分析
  • 公司简介
    • Shimadzu Corporation

第四章调查方法

Product Code: BHL2516SS

Introduction to Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market

The Asia-Pacific mass spectrometry and chromatography in diagnostics market was valued at $154.2 million in 2024 and is expected to reach $428.7 million by 2033, growing at a CAGR of 12.04% during the forecast period 2024-2033. The APAC Mass Spectrometry (MS) and Chromatography Market is a key player in the analytical and life sciences instrumentation sector, providing cutting-edge solutions for the separation, identification, and quantification of biological and chemical objects. Numerous industries, including pharmaceuticals, environmental monitoring, diagnostics, and food safety, have advanced significantly as a result of these technologies.

Instead of being used separately, mass spectrometry and chromatography are usually incorporated into workflows in diagnostics. For example, liquid chromatography-mass spectrometry (LC-MS) is a highly effective method for complex sample analysis because it combines the detection capabilities of mass spectrometry with the separation efficiency of liquid chromatography. In clinical settings, where accurate diagnosis and treatment planning are made possible by high-throughput analysis of patient samples, this integration is especially beneficial.

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$154.2 Million
2033 Forecast$428.7 Million
CAGR12.04%

Important diagnostic uses for chromatography and mass spectrometry in the APAC region include vitamin profiling, hormone analysis, and biomarker discovery. With increasing adoption in precision medicine, metabolomics, and proteomics, these technologies are expected to see widespread growth, driven by rising healthcare investments, technological advancements, and expanding access to advanced diagnostic tools.

Market Introduction

The market for APAC mass spectrometry and chromatography in diagnostics is expanding significantly due to the rising complexity of clinical diagnostics and the growing need for precision medicine. Mass spectrometry (MS) and chromatography are vital tools in the diagnosis and monitoring of many diseases, such as cancer, metabolic disorders, and infectious diseases, because they are necessary for the separation, identification, and quantification of chemical and biological substances.

High-throughput, precise analysis of patient samples is made possible by technologies like liquid chromatography-mass spectrometry (LC-MS), which are being widely used in diagnostic workflows. These hybrid systems provide complete solutions for intricate sample analysis in clinical settings by fusing mass analysis and separation capabilities. They play a key role in proteomics, metabolomics, and biomarker discovery, which enhances diagnostic capabilities and personalized medicine.

Targeted drug testing, metabolic analysis, and vitamin and hormone profiling are important diagnostic applications. The need for these cutting-edge diagnostic tools is being driven by the increased focus on early disease detection and individualized treatment plans.

Government programs for early detection, growing healthcare infrastructure, and technological developments like automation and AI-driven analytics all contribute to market expansion. The market for mass spectrometry and chromatography is expected to keep growing as APAC's healthcare systems embrace more sophisticated diagnostic tools, which will enhance patient outcomes and healthcare effectiveness throughout the region.

Market Segmentation

Segmentation 1: by Product Type

  • Sample Preparation
  • Mass Spectrometry and Chromatography

Segmentation 2: by Application Type

  • Therapeutic Drug Monitoring
  • Vitamins
  • Hormones
  • Methylmalonic Acid
  • Immunosuppressants
  • Others

Segmentation 3: by Region

  • Asia-Pacific
    • Japan
    • India
    • China
    • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific mass spectrometry and chromatography in diagnostics market has been segmented based on various categories, such as by product type, application type, and country.

Competitive Strategy: The Asia-Pacific mass spectrometry and chromatography market consists of various public and few private companies. Key players in the mass spectrometry and chromatography in diagnostics market analyzed and profiled in the study involve established players that offer various kinds of products.

Table of Contents

Executive Summary

Scope and Definition

1 Mass Spectrometry and Chromatography in Diagnostics Market: Industry Outlook

  • 1.1 Market Overview
  • 1.2 Key Trends
    • 1.2.1 Shift toward Utilization of Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) as Standard Technique in Diagnostics
    • 1.2.2 Utilization of Automated Sample Preparation Technologies
  • 1.3 Opportunity Assessment of Key Trends
  • 1.4 Product Benchmarking
  • 1.5 Regulatory Landscape
    • 1.5.1 Regulatory Framework in Asia-Pacific
      • 1.5.1.1 China

2 Mass Spectrometry and Chromatography in Diagnostics Market (by Region)

  • 2.1 Regional Summary
  • 2.2 Asia-Pacific
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
    • 2.2.4 By Product Type
    • 2.2.5 By Application Type
    • 2.2.6 Japan
      • 2.2.6.1 By Product Type
      • 2.2.6.2 By Application Type
    • 2.2.7 China
      • 2.2.7.1 By Product Type
      • 2.2.7.2 By Application Type
    • 2.2.8 India
      • 2.2.8.1 By Product Type
      • 2.2.8.2 By Application Type
    • 2.2.9 Rest-of-Asia-Pacific
      • 2.2.9.1 By Product Type
      • 2.2.9.2 By Application Type

3 Mass Spectrometry and Chromatography in Diagnostics Market: Competitive Benchmarking and Company Profile

  • 3.1 Competitive Landscape
    • 3.1.1 Partnerships, Alliances, and Business Expansions
    • 3.1.2 New Offerings
    • 3.1.3 Mergers and Acquisitions
    • 3.1.4 Regulatory Approvals
  • 3.2 Key Strategies and Development
  • 3.3 Company Competition Matrix
  • 3.4 Company Share Analysis
  • 3.5 Company Profiles
    • 3.5.1 Shimadzu Corporation
      • 3.5.1.1 Overview
      • 3.5.1.2 Top Products
      • 3.5.1.3 Top Competitors
      • 3.5.1.4 Top Customers
      • 3.5.1.5 Key Personnel
      • 3.5.1.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation

List of Figures

  • Figure 1: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2024, 2028, and 2033
  • Figure 2: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023, 2027, and 2033
  • Figure 3: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Application), $Million, 2023, 2027, and 2033
  • Figure 4: Product Benchmarking (Mass Spectrometry and Chromatography (by Instruments))
  • Figure 5: Japan Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 6: China Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 7: India Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 8: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market, $Million, 2023-2033
  • Figure 9: Partnerships, Alliances, and Business Expansions, January 2015- June 2024
  • Figure 10: New Offerings, January 2015- June 2024
  • Figure 11: Mergers and Acquisitions, January 2015- June 2024
  • Figure 12: New Offerings, January 2015- June 2024
  • Figure 13: Mass Spectrometry and Chromatography in Diagnostics Market, Company Competition Matrix
  • Figure 14: Mass Spectrometry and Chromatography in Diagnostics Market, % Share, 2023
  • Figure 15: Data Triangulation
  • Figure 16: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Current State and Future Potential of Key Trends in the Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market
  • Table 3: Mass Spectrometry and Chromatography in Diagnostics Market (by Region), $Million, 2023-2033
  • Table 4: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 5: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 6: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 7: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 8: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 9: Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 10: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 11: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 12: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 13: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 14: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 15: Japan Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 16: China Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 17: China Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 18: China Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 19: China Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 20: China Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 21: China Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 22: India Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 23: India Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 24: India Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 25: India Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 26: India Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 27: India Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 28: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type), $Million, 2023-2033
  • Table 29: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Preparation), $Million, 2023-2033
  • Table 30: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Mass Spectrometry and Chromatography), $Million, 2023-2033
  • Table 31: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type), $Million, 2023-2033
  • Table 32: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Vitamins), $Million, 2023-2033
  • Table 33: Rest-of-Asia-Pacific Mass Spectrometry and Chromatography in Diagnostics Market (by Hormones), $Million, 2023-2033
  • Table 34: Mass Spectrometry and Chromatography in Diagnostics Market, Key Development Analysis, January 2015-June 2024